ABSTMCT
GH controls its own secretion through a mechanism involving short-loop feedback regulation of the synthesis and release of GHreleasing hormone (GHRH). GHRH neurons coexpress the peptide galanin, but the functional significance of this coexpression is un-. known.
In this study, we tested the hypotheses that 1) galanin gene expression in GHRH neurons is regulated by GH and 2) somatostatin (SS) or GHRH neurons are a target for the action of galanin in the hypothalamus.
First, we compared levels of galanin messenger RNA (mRNA) in GHRH neurons between normal male rats and Lewis dwarf rats, which have markedly reduced blood levels of GH. The brains of normal and dwarf animals were processed for detection of galanin mRNA and GHRH mRNA by double-label in situ hybridization. We observed that Lewis dwarf rats had significantly reduced levels of galanin mRNA in their GHRH neurons (P < 0.05). Next, we tested the hypothesis that GH regulates galanin gene expression in GHRH neurons by experimentally altering circulating levels of GH. Three groups of adult male rats were used: 1) intact rats (n = 7); 2) hypophysectomized (hypox) rats (n = 7); and 3) hypox rats treated with 1.5 mg of rat GH (rGH) over a 3-day period (n = 6). [5303] [5304] [5305] [5306] [5307] [5308] [5309] [5310] 1996) THE SECRETION OF GH is governed by the actions of 1 two hypothalamic hormo:es, .somato&tatin (SS) and GH-releasing hormone (GHRH), which inhibit and stimulate the synthesis and secretion of GH, respectively (1). SS secreted from axon terminals in the median eminence is produced by neurons whose cell bodies reside primarily in the periventricular nucleus (PeN), and GHRH is produced by neurons with cell bodies in the arcuate nucleus (ARC). GH participates in the homeostatic control of its own secretion through a mechanism involving reciprocal regulation of the synthesis and secretion of SS and GHRH by GH (see 2 for review). While these relationships comprise the basic elements of the short-loop feedback regulation of GH secretion, an additional, potentially important, component of this control system may be the neuropeptide galanin which is coexpressed in GHRH neurons (3, 4). In the brain, galanin is colocalized with a variety of classical neurotransmitter and neuropeptide systems (e.g. acetylcholine and vasopressin), where it is thought to act as a neuromodulator (5,6). A role for galanin in the regulation of GH secretion has been postulated based on the observations that galanin stimulates the secretion of GH (7-9), whereas galanin antiserum reduces GH pulse amplitude and increases the frequency of GH pulses (10). Although the source of endogenous galanin involved in the physiological regulation of GH secretion is unknown, several lines of evidence suggest that galanin expressed in GHRH neurons is important. First, as in the case with GHRH messenger RNA (mRNA), galanin mRNA levels in GHRH neurons increase over the course of development, in parallel with the amplification of pulsatile GH secretion (11-13). Second, just as the circulating patterns of GH are sexually differentiated and amplified by androgens in the rat (14), levels of galanin mRNA in GHRH neurons are also sexually differentiated and increased by androgens, in parallel with cellular levels of GHRH mRNA (12, 13 galanin mRNA in GHRH neurons among 3 other groups of male rats whose circulating GH levels were experimentally altered. The target cells for the action of galanin in the regulation of GH secretion are unknown. It is conceivable that galanin acts directly on either SS-or GHRH-producing neurons to regulate their secretory activity, which could then modulate GH secretion (16, 10). There is anatomical evidence for synaptic contacts between galanin-containing axon terminals and the dendrites and cell bodies of SS-containing neurons in the anterior region of the PeN (17); however, it is unclear whether galanin acts either pre-or postsynaptically at this putative synapse. We argued that if galanin exerts an effect on SS or GHRH neurons, then the target neuron should express the galanin receptor. To test this hypothesis, we cloned a rat galanin receptor cDNA, and using double-label in sifu hybridization, we determined whether SS and GHRH neurons express this galanin receptor mRNA.
Materials and Methods

Animal accommodations
For A group of hypox rats were treated with rGH for 3 days (n = 6). Another group of hypox rats (n = 7) and a group of normal (intact) rats (n = 7) received vehicle for the same length of time. At the end of the treatment period, the rats were killed and their brains and trunk blood were collected. The brains were processed for GHRH mRNA and galanin mRNA by doublelabel jr1 situ hybridization, and serum levels of rGH were measured by RIA.
Exp 3. Adult male rats (n = 3) were killed and brains were collected and sectioned. to determine empirically the optimal concentration for these probes.
The slide was covered with a silanized coverslip, and the sections were incubated overnight in moist chambers at 60 C. On the following day, the coverslips were rinsed off in 2 X SSC. Following treatment with RNase A and a series of washes in SSC of increasing stringencies, the slides were placed in a blocking buffer containing 2 X SSC, 0.05% Triton X-100 and 2% normal sheep serum (NSS) for 60-min.
The slides were washed in buffer 1 (100 rn; Tris-HCl, pH 7.5, and 150 rnM NaCl) for 30 min and then incubated for 3 h at 37 C with antidigoxigenin antibody conjugated to alkaline phosphatase (Boehringer Mannheim Biochemica, Indianapolis, IN; 1:lOOO in buffer 1 containing 1% NSS and 0.3% Triton X-100). The slides were washed in buffer 1 again and rinsed in buffer 2 (100 rnM Tris-HCl, 100 rnM NaCl, 50 rnM MgCl*, pH 9.5) for 10 min; they were then incubated in buffer 2 with 340 uz/ml nitro-blue-tetrazolium-chloride [Sigma, St. Louis, MO) and 175 $;rnl 5-bromo-4-chloro-3-indolyl-phospKate'(Sigma, St. Louis, MO), and 240 pg/ ml levamisole in a light-tight box for 3 h at 37 C. The reaction was stopped by rinsing the slides in 10 rnM Tris-HCI, pH 8.0, and 1 rnM EDTA.
The slides were placed in 70% ethanol for 15 set, air-dried, dipped in 3% parlodion (Fisher Scientific, Fair Lawn, NJ) dissolved in isoamyl acetate, and allowed to air-dry. The slides were then dipped in, for Exps 1 and 2, Kodak NTB-2 and, for Exp 3, Kodak NTB-3 emulsion (Eastman Kodak, Rochester, NY), heated to 45 C in a water bath and diluted 1:l with 600 rnM ammonium acetate and distilled water, respectively. They were air-dried for 45 min and placed in light-tight boxes containing small tubes of desiccant and were exposed at 4 C. 
Statistical analysis
Unless otherwise noted, all data are presented as mean ? SEM. The "n" refers to the number of animals within a group, and this was the "n" used in the data analysis.
For As illustrated in Fig. 1 , galanin mRNA levels in GHRH neurons, reflected as grains per cell, were reduced by 47% in the dwarfs, compared with controls (P < 0.05). Levels of IGF-1 in the serum of control Lewis strain rats were 434 ? 23 rig/ml, whereas levels were less than 261 ? 51 rig/ml in the dwarf rats, indirectly verifying the state of GH deficiency in the Lewis derived dwarf rats.
Galanin mRNA coexpression in ARC GHRH neurons varied as a function of GH state (Fig. 2) . As shown in Fig. 3 , galanin mRNA levels in GHRH neurons in the ARC were significantly less in hypox (vehicle-treated) animals, compared with the group of intact (vehicle-treated) animals and the group of hypox animals treated with rGH (P < 0.0001). There was no significant difference between the vehicletreated intact group and the rGH-treated hypox group. Levels of GH in the serum of normal male rats were 51 2 25 ng / ml, whereas levels were less than 1 ng / ml in hypox rats. Levels of GH were within the physiological range (94 ? 12 ng/ ml) in 5 of the hypox rats that were treated with rGH. In the sixth rGH-treated hypox rat, the minipump was severed at the time of sacrifice, contaminating the trunk blood that was collected, and the GH level was not included in the analysis. Fig.  4 . Galanin receptor mRNA levels were significantly higher than background levels in SS neurons in the I'eN (P < 0.0001) but were indistinguishable from background in cortical SS neurons (P > 0.5) and GHRH neurons in the ventromedial nucleus of the hypothalamus (VMH) (P > 0.8). Although galanin receptor mRNA signal levels in ARC GHRH and SS neurons appeared to be slightly (but significantly) higher than background, these levels were not significantly different from galanin receptor mRNA levels in cortical SS neurons (P > 0.15 and P > 0.45, respectively). The percentage of SS and GHRH cells determined to coexpress galanin receptor mRNA is dependent upon the sensitivity of the irz situ assay, the characteristics of the probe, and the acceptance criterion for calling a particular cell "double-labeled." For example, if all of the SS neurons in the I'eN do, in fact, express galanin receptor mRNA, the percentage of SS cells identified as double-labeled will vary directly with the sensitivity of the assay for detecting the galanin receptor mRNA. To illustrate the uncertainty and difficulty of determining the actual percentage of neurons coexpressing galanin receptor mRNA, in Fig.  5 we show how the percentage of SS and GHRH neurons determined to express galanin receptor mRNA varies as a function of the signal to background acceptance criterion. A relatively low signal/background criterion of 3 would classify approximately 60% of the SS neurons in the I'eN as containing galanin receptor mRNA and approximately 20-30% of the SS and GHRH neurons in the ARC, and SS neurons in the cortex as being double-labeled. The application of a more conservative criterion of 6 would result in approximately 35% of the SS neurons in the PeN and approximately 5% of the GHRH and SS neurons in the ARC being classified as double-labeled.
Discussion
The SS and GHRH genes are targets for GH regulation. Chomczynski and his colleagues have shown that GH inhibits hypothalamic GHRH gene expression (31), whereas our own work has demonstrated that GH stimulates the expression of the SS gene in neurons of the hypothalamic PeN (24). We have also reported that mRNA levels of SS and GHRH vary inversely with one another as a function of the ultradian rhythm of GH secretion (32). The reciprocal regulation of SS and GHRH gene expression by GH identifies the fundamental elements governing the relationship between circulating levels of GH and the feedback control of SS and GHRH synthesis. The results of our present experiments refine this basic model by adding galanin as a target gene in GHRH neurons for the stimulatory action of GH in the hypothalamus of the rat.
Our studies were presaged by the earlier studies of Selvais ef ul. (33), who showed that hypophysectomy reduces hypothalamic content of galanin and galanin mRNA in the rat. In a follow-up study, this same group showed that replacement with GH alone did not reverse the effects of hypophysectomy but that only a combined replacement regimen of Td, cortisol, estradiol, and GH induced recovery of galanin mRNA in hypophysectomized animals (34). Our own results show that if the analysis is focused only on galanin mRNA expression in GHRH neurons, GH alone does reverse the inhibition of galanin expression caused by hypophysectomy-a result that would likely have been obscurred in Northern blot analysis used by the Selvais group. Indeed, there are thousands of galanin-expressing neurons in the forebrain with many different phenotypes among them, some of which may be sensitive to estrogen or glucocorticoids with others being sensitive to GH, thyroid hormone, or some combination of these factors (see for example Ref. 35 ). The double-labeling technique permits focus on a single phenotype among the diverse array of these heterogenous cells, and the results demonstrate that galanin expression in GHRH neurons is regulated by GH. It is also notable that since a constant infusion of GH produced by the minipumps completely reversed the effects of hypophysectomy on galanin expression in GHRH neurons, a pulsatile pattern of GH secretion does not appear to be essential for the maintenance of normal galanin expression in GHRH neurons.
The observation that GH induces galanin gene expression in GHRH neurons but suppresses the expression of the GHRH gene in the same cells suggests that GH acts on GHRH neurons via two different mechanisms, one stimulatory and the other inhibitory. We have previously shown that most GHRH neurons do not appear to respond directly to GH (36), so it seems likely that other GH-sensitive neurons relay the GH signal irzdirecfly to GHRH neurons. Considerable evidence suggests that two neuronal systems may be involved in the relay function. The first is the population of SS neurons whose cell bodies reside in the I'eN; these SS neurons express the GH receptor (28), and appear to make direct synaptic contact with GHRH neurons in the ARC (37). The second is the population of NI'Y neurons whose cell bodies are in the ARC. These NI'Y neurons express the GH receptor (29) and exhibit c-fos induction following acute exposure to GH (38). Hence, it is conceivable that one of these populations, either NI'Y neurons in the ARC or SS neurons in the PeN, mediates the stimulatory effects of GH on galanin gene expression in GHRH neurons and the other mediates the inhibitory effects of GH on GHRH gene expression.
The galanin synthesized in GHRH neurons is likely to be involved in the regulation of GH secretion, but the site of its action remains to be determined. Galanin from GHRH neurons may act either within the brain as a neurotransmitter or, following its release into the hypophysial portal system, at the anterior pituitary as a hypophysiotropic factor. Infusions of galanin, either by intracerebroventricular or peripheral routes, induce GH secretion (9, 39). Galanin binding sites have been identified in the anterior pituitary and galanin has been proposed to have direct post-synaptic effects at the pituitary (40-43); however, several in ZG~YO studies have shown that galanin is ineffective in evoking GH secretion GHRH mFiNA/Galanin receptor mRNA from cultured pituitary cells (9, 44) . Acting at the hypothalamic level, galanin could induce GH secretion either by facilitating the release of GHRH or inhibiting the release of SS. The observation that GHRH antiserum blocks galanininduced GH secretion has been used as evidence to suggest that the effects of galanin are mediated by GHRH neurons (16). However, since somatostatin can influence the release of GH from somatotropes only in the presence of GHRH, this observation does not rule out an action of galanin on SS instead of, or in addition to, an action on GHRH. Furthermore, galanin potentiates the GH response to GHRH infusion (8) and pretreatment with SS antiserum diminishes galanin-induced GH secretion (45, 46) , suggesting here that galanin may induce GH secretion by inhibiting the SS pathway. Therefore, the most parsimonious explanation for the collective results to date points to SS neurons being the primary hypothalamic target for the action of galanin on GH secretion. This possibility is further supported by evidence that galaninergic fibers synapse on SS neurons in the I'eN (17).
The origin of galaninergic connections to SS neurons in the PeN has not yet been characterized. Nevertheless, both galanin and GHRH are neurotransmitter candidates at these synapses, because GHRH neurons express galanin mRNA and there is evidence for GHRH neurons making direct synaptic contact with SS neurons (37 Based on the current state of knowledge on the expression of the GH receptor in SS and NPY neurons, the synaptic interactions among the various populations of neuropeptidecontaining neurons, and the expression of the galanin receptor by SS neurons, we postulate a model for the short-loop feedback control of GH secretion and the putative role of SS, GHRH, galanin, and NI'Y in effecting this interaction (see Fig. 6 ). In this model, SS neurons in the PeN and NI'Y neurons in the ARC are the primary targets for receiving feedback information about circulating levels of GH. GH stimulates the synthesis of both SS and NPY, and with some delay, enhances secretion of these neuropeptides.
We postulate that both NPY and SS act on GHRH/ galanin neurons, although the precise molecular basis of their actions on these neurons is unknown, since there are many different NPY and SS receptor subtypes. (This is an important area for future investigations.) Acting through either SS or NPY neurons, GH inhibits the expression of the GHRH gene and stimulates expression of the galanin gene. After some delay, GHRH/ galanin neurons become activated and GHRH is released into the portal circulation to stimulate GH secretion, while at the same time, galanin is released at synapses on cell bodies or dendrites of SS neurons in the PeN. Galanin suppresses SS gene expression and diminishes the secretory activity of these SS neurons, for as long as the readily releasable stores of GHRH and galanin permit. Once these stores of GHRH and galanin are depleted, the process shifts to enhanced SS secretion, whose stores have been replenished by the action of GH on SS synthesis. These interactions allow for communication among the relevant populations of neurons, and given the time necessary for transcriptional events to be translated into proteins and for proteins to transport to axon terminals, the reciprocal events become expressed as the ultradian rhythm in GH secretion (32). According to this model, galanin accentuates the pulsatile nature of GH secretion by inhibiting SS release, and subsequently reducing SS inhibition of GH and GHRH release during pulse generation. This is in agreement with evidence that the administration of galanin antiserum reduces pulse amplitude in male rats (10). It is also consistent with what is known about the relationship between galanin mRNA levels in GHRH neurons and pulsatile GH secretion. In the adult rat, GH pulse amplitude is much greater in the male than in the female (14) and the level of galanin mRNA expression in GHRH neurons is also considerably higher in males than females (13). Galanin mRNA levels in GHRH neurons increase across pubertal development in the male rat (13), in parallel with a dramatic increase in the amplitude of pulsatile GH secretion (11, 14) . Finally, in the adult male, testosterone increases both the amplitude of GH pulses and the expression of galanin mRNA in GHRH neurons (14,13). Therefore, even though the model we have proposed should be considered preliminary, it is consistent with the available evidence and should provide a useful framework for the design and interpretation of future studies.
